A Markov chain model to assess the efficacy of screening for non-insulin dependent diabetes mellitus (NIDDM)

International Journal of Epidemiology

Volumn 28, Issue 2, 1999, Pages 233-240

  Kuo, H S ^a   Chang, H J ^c   Chou, P ^a   Teng, L ^a   Chen, Tony H H ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NONE

Author keywords

Markov chain model; NIDDM screening

Indexed keywords

ADULT; AGED; ARTICLE; DEATH; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; SCREENING; TAIWAN;

EID: 0032920629     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/28.2.233     Document Type: Article

References (18)

1. Chou P, Liao MJ, Kuo HS et al. A population survey on prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care 1994;17:1055-58.
2. Chou P, Chen HH, Hsiao KJ. Community-based epidemiological study on diabetes in Pu-Li, Taiwan. Diabetes Care 1992;15:81-89.
3. Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst 1980;64:1263-72.
4. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992;15:815-19.
5. Jarrett RJ. Duration of non-insulin dependent diabetes and development of retinopathy: analysis of possible risk factors. Diabetic Med 1986;3:261-63.
6. Day NE, Walter SD. Simplified models of screening for chronic disease: estimation procedures from mass screening programs. Biometrics 1984;40:1-14.
7. Duffy SW, Chen HH, Tabar L, Day NE. Estimation of mean sojourn time in breast cancer screening using a Markov Chain Model of both entry to and exit from the preclinical detectable phase. Stat Med 1995;14:1531-43.
8. Marshall G, Jones RH. Multi-state models and diabetic retinopathy. Stat Med 1995;14:1975-83.
9. van Oortmarssen GJ, Boer R, Habbema JDF. Modelling issues in cancer screening. Stat Method Med Res 1995;4:33-54.
10. van Oortmarssen GJ, Habbema JDF, Lubbe JTN, van der Maas PJ. A model-based analysis of the HIP-project for breast cancer screening. Int J Cancer 1990;46:207-13.
11. Parkin DM. A computer simulation model for the practical planning of cervical cancer screening programmes. Br J Cancer 1985;51: 551-68.
12. Kao EPC. An Introduction to Stochastic Processes. Duxbury, 1997.
13. SAS Institute Inc. SAS/STAT User's Guide, Version 6, Fourth Edition. Volume 2. Cary, NC: SAS Institute Inc., 1989.
14. Etzioni RD, Connor RJ, Prorok PC, Self SG. Design and analysis of cancer screening trials. Stat Method Med Res 1995;4:3-17.
15. Brookmeyer R, Gail MH. AIDS Epidemiology: A Quantitative Approach. Oxford: Oxford University Press, 1994.
16. Morrish NJ, Steven LK, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetes patients (London cohort of the WHO Multination Study of Vascular Disease in Diabetes) I: causes and death rates. Diabetologia 1990;33:538-41.
17. Lee ET, Russell D, Jorge N, Kenny S, Yu ML. A follow-up study of diabetic Oklahoma Indians: mortality and causes of death. Diabetes Care 1993;16:300-05.
18. Walter SD, Stitt LW. Evaluation the survival of cancer cases detected by screening. Stat Med 1987;6:885-900.